Open AccessTherapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease
Author(s) -
Stéphane Paul,
Émilie Del Tedesco,
Hubert Marotte,
Mélanie Rinaudo-Gaujous,
A Moreau,
Jean–Marc Phelip,
Christian Genin,
Laurent PeyrinBiroulet,
Xavier Roblin
Publication year - 2013
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1097/mib.0b013e3182a77b41
Subject(s) - medicine , infliximab , calprotectin , gastroenterology , ulcerative colitis , inflammatory bowel disease , therapeutic drug monitoring , faecal calprotectin , trough level , crohn's disease , pharmacokinetics , disease , transplantation , tacrolimus
Data on the value of therapeutic drug monitoring of infliximab (IFX) to predict mucosal healing (MH) in inflammatory bowel diseases (IBD) are scarce.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom